Niowave, Lansing, Mich., will get $13 million from the National Nuclear Security Administration, under a cooperative agreement, to support domestic production of the Molybdenum-99 medical isotope, the agency announced Dec. 3.
This is the fourth and final round…
SUBSCRIBER ACCESS
Thank you for visiting
Nuclear Security & Deterrence Monitor!
You must be logged in as a subscriber to view this page.






